Clinical Trial Update: A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating azacitidine (5-AZA) and all-trans retinoic acid (ATRA) for PSA-only recurrence of prostate cancer after local treatment; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• All-trans Retinoic Acid (all-trans retinoic acid)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Prostatic Neoplasms, Prostate Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2024-04-30